v3.25.2
Condensed Statements of Changes in Stockholders' Deficit - USD ($)
$ in Thousands
Total
Public Equity Offering - ATM
Public Equity Offering
Common Stock
Common Stock
Public Equity Offering - ATM
Additional Paid-in Capital
Additional Paid-in Capital
Public Equity Offering - ATM
Additional Paid-in Capital
Public Equity Offering
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023       68,533,085          
Beginning balance at Dec. 31, 2023 $ (106,487)     $ 69   $ 212,521     $ (319,077)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued under public equity offering (in shares)       16,666,667 4,557,220        
Common Stock issued under public equity offering 75,000 $ 12,385   $ 17 $ 4 74,983 $ 12,381    
Costs of common stock issued under public equity offering-ATM   (410)         (410)    
Costs of common stock issued under public equity offering     $ (5,187)         $ (5,187)  
Share-based compensation expense 1,580         1,580      
Vested restricted stock units, net (in shares)       490,359          
Vested restricted stock units, net (893)         (893)      
Options exercises, net (in shares)       231,400          
Options exercised, net 539         539      
Net loss (12,828)               (12,828)
Ending balance (in shares) at Mar. 31, 2024       90,478,731          
Ending balance at Mar. 31, 2024 (36,301)     $ 90   295,514     (331,905)
Beginning balance (in shares) at Dec. 31, 2023       68,533,085          
Beginning balance at Dec. 31, 2023 (106,487)     $ 69   212,521     (319,077)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (15,573)                
Ending balance (in shares) at Jun. 30, 2024       91,059,760          
Ending balance at Jun. 30, 2024 (35,479)     $ 91   299,080     (334,650)
Beginning balance (in shares) at Mar. 31, 2024       90,478,731          
Beginning balance at Mar. 31, 2024 (36,301)     $ 90   295,514     (331,905)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued under public equity offering (in shares)         559,801        
Common Stock issued under public equity offering   2,520     $ 1   2,519    
Costs of common stock issued under public equity offering-ATM   (158)         (158)    
Costs of common stock issued under public equity offering     $ (359)         $ (359)  
Share-based compensation expense 1,523         1,523      
Vested restricted stock units, net (in shares)       3,512          
Vested restricted stock units, net (5)         (5)      
Shares issued under employee stock purchase plan (in shares)       17,716          
Shares issued under employee stock purchase plan 46         46      
Net loss (2,745)               (2,745)
Ending balance (in shares) at Jun. 30, 2024       91,059,760          
Ending balance at Jun. 30, 2024 (35,479)     $ 91   299,080     (334,650)
Beginning balance (in shares) at Dec. 31, 2024       91,413,742          
Beginning balance at Dec. 31, 2024 (60,156)     $ 91   302,967     (363,214)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued under public equity offering (in shares)         7,457,627        
Common Stock issued under public equity offering   22,000     $ 8   21,992    
Costs of common stock issued under public equity offering-ATM   $ (729)         $ (729)    
Share-based compensation expense 1,587         1,587      
Vested restricted stock units, net (in shares)       445,784          
Vested restricted stock units, net (702)         (702)      
Net loss (22,930)               (22,930)
Ending balance (in shares) at Mar. 31, 2025       99,317,153          
Ending balance at Mar. 31, 2025 (60,930)     $ 99   325,115     (386,144)
Beginning balance (in shares) at Dec. 31, 2024       91,413,742          
Beginning balance at Dec. 31, 2024 (60,156)     $ 91   302,967     (363,214)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (36,478)                
Ending balance (in shares) at Jun. 30, 2025       99,353,270          
Ending balance at Jun. 30, 2025 (72,590)     $ 99   327,003     (399,692)
Beginning balance (in shares) at Mar. 31, 2025       99,317,153          
Beginning balance at Mar. 31, 2025 (60,930)     $ 99   325,115     (386,144)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Costs of common stock issued under public equity offering-ATM (34)         (34)      
Share-based compensation expense 1,875         1,875      
Vested restricted stock units, net (in shares)       10,561          
Vested restricted stock units, net $ (19)         (19)      
Options exercises, net (in shares) 7,500                
Options exercised, net $ 7         7      
Shares issued under employee stock purchase plan (in shares)       18,056          
Shares issued under employee stock purchase plan 59         59      
Net loss (13,548)               (13,548)
Ending balance (in shares) at Jun. 30, 2025       99,353,270          
Ending balance at Jun. 30, 2025 $ (72,590)     $ 99   $ 327,003     $ (399,692)